Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19

Individuals with oncohematological diseases (OHD) may develop an impaired immune response against vaccines due to the characteristics of the disease or to its treatment. Humoral response against SARS-CoV-2 has been described to be suboptimal in these patients, but the quality and efficiency of the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Mora, Sara, Corona, Magdalena, Torres, Montserrat, Casado-Fernández, Guiomar, García-Pérez, Javier, Ramos-Martín, Fernando, Vigón, Lorena, Manzanares, Mario, Mateos, Elena, Martín-Moro, Fernando, Zurdo-Castronuño, Alejandro, Murciano-Antón, María Aranzazu, Alcamí, José, Pérez-Olmeda, Mayte, López-Jiménez, Javier, García-Gutiérrez, Valentín, Coiras, Mayte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147947/
https://www.ncbi.nlm.nih.gov/pubmed/35628927
http://dx.doi.org/10.3390/jcm11102803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147947/
https://www.ncbi.nlm.nih.gov/pubmed/35628927
http://dx.doi.org/10.3390/jcm11102803

Ejemplares similares